Table 2 Clinical variables related to 30-day mortality in the administration of teicoplanin

Patient information

 Sex [female vs. male]

1.26

1.05‒1.51

0.014

1.29

1.06‒1.57

0.013

Treatment details

 Treatment duration (day)

0.94

0.93‒0.95

 < 0.001

0.94

0.93‒0.95

 < 0.001

 Total dose for 3 days [≤ 1,600 mg vs. 1,600 <]

1.14

1.01‒1.30

0.032

1.20

1.04‒1.39

0.013

Reimbursement

 Treatment and management fee for specific drugs

1.04

0.88‒1.24

0.63

1.12

0.91‒1.37

0.28

 Drug management and guidance fee

0.44

0.37‒0.53

 < 0.001

0.45

0.36‒0.55

 < 0.001